Yunus, Junaedy and Salman, Mohammad and Lintin, Gabriella Bamba Ratih and Muchtar, Masita and Sari, Dwi Cahyani Ratna and Arfian, Nur and Romi, Muhammad Mansyur (2020) Chlorogenic acid attenuates kidney fibrosis via antifibrotic action of bmp-7 and hgf. Medical Journal of Malaysia, 75. 5 - 9. ISSN 03005283
Full text not available from this repository. (Request a copy)Abstract
Background: Kidney fibrosis, characterised by tubulointerstitial fibrosis, is a histological landmark of chronic kidney disease. The body attempts to compensate for progressive detrimental process of kidney fibrosis by producing antifibrotic substances, such as bone morphogenetic protein-7 (BMP-7) and hepatocyte growth factor (HGF). Chlorogenic acid is known to have renoprotective and antifibrotic properties. This study aims to evaluate the effect of chlorogenic acid on unilateral ureteral obstruction (UUO)-induced kidney fibrosis mice model. Methods: This study was a quasi-experimental with posttest-only control group design. Twenty-five adult male Swiss Webster mice were randomly divided into five groups: sham-operated group (SO), UUO-control day-7 (U7), UUO-control day-14 (U14), UUO-chlorogenic acid day-7 (UC7), and UUO-chlorogenic acid day 14 (UC14). Myofibroblasts were identified by immunohistochemical staining of alpha-smooth muscle actin (α-SMA) while collagen fibers were identified by Sirius Red staining. Both data were presented as area fraction. BMP-7 and HGF mRNA expressions were assessed by reverse transcription PCR (RT-PCR). Data were quantified using ImageJ software. Results: UUO-control groups (U7 and U14) showed higher α-SMA-immunopositive (6.52±1.33, 18.24±1.39 vs. 0.22±0.01; p<0.05) and Sirius Red-positive area fractions (6.61±0.8, 12.98±2.31 vs. 0.62±0.10; p<0.05), lower BMP-7 (1.02±0.47, 1.18±0.65 vs. 2.09±0.87; p<0.05) and HGF mRNA expressions (1.06±0.31, 0.89±0.14 vs. 1.88±0.81; p<0.05) compared to SO group. UUO-chlorogenic acid groups (UC7 and UC14) showed lower α-SMA-immunopositive (1.24±0.37, 4.58±0.61; p<0.05) and Sirius Red-positive area fractions (4.76±1.03, 3.72±0.54; p<0.05), higher BMP-7 (1.84±0.49, 2.19±0.43; p<0.05) and HGF (1.58±0.38; p>0.05, 1.84±0.42; p<0.05) mRNA expressions compared to UUO-control groups. UUO-chlorogenic acid groups showed BMP-7 and HGF mRNA expressions that were not significantly different from the SO group. Conclusion: Chlorogenic acid administration prevents kidney fibrosis in UUO mice model through modulating antifibrotic pathway. © 2020 Elsevier B.V., All rights reserved.
| Item Type: | Article |
|---|---|
| Additional Information: | Cited by: 13 |
| Uncontrolled Keywords: | alpha smooth muscle actin; antifibrotic agent; chlorogenic acid; scatter factor; BMP7 protein, human; osteogenic protein 1; adult; animal experiment; animal model; animal tissue; antifibrotic activity; Article; collagen fiber; controlled study; gene expression; immunohistochemistry; kidney fibrosis; liver cell; male; mouse; myofibroblast; nonhuman; protein expression; real time polymerase chain reaction; reverse transcription polymerase chain reaction; RNA extraction; ureter obstruction; animal; complication; fibrosis; kidney disease; metabolism; randomization; Animals; Bone Morphogenetic Protein 7; Chlorogenic Acid; Fibrosis; Hepatocyte Growth Factor; Kidney Diseases; Mice; Random Allocation; Ureteral Obstruction |
| Subjects: | R Medicine > RB Biomedical Sciences |
| Divisions: | Faculty of Medicine, Public Health and Nursing > Biomedical Sciences |
| Depositing User: | Sri JUNANDI |
| Date Deposited: | 28 Oct 2025 01:59 |
| Last Modified: | 28 Oct 2025 01:59 |
| URI: | https://ir.lib.ugm.ac.id/id/eprint/23304 |
